Duncan Spalding

发表

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

R. Plummer, T. Meyer, J. Rossi, 2020, Clinical Cancer Research.

Meta‐analysis of drain amylase content on postoperative day 1 as a predictor of pancreatic fistula following pancreatic resection

L. Jiao, M. Pai, A. Giakoustidis, 2016, The British journal of surgery.

Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: An international multicentre retrospective cohort study.

M. Maglione, M. Pai, P. Lapolla, 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.

M. Maglione, M. Pai, P. Lapolla, 2024, HPB : the official journal of the International Hepato Pancreato Biliary Association.